Free Trial

Amplifon (OTCMKTS:AMFPF) Stock Price Up 12.3% - Here's Why

Amplifon logo with Medical background

Key Points

  • Amplifon S.p.A. stock surged by 12.3% on Tuesday, reaching a trading high of $18.09, with an impressive 612% increase in trading volume.
  • Morgan Stanley reaffirmed an "overweight" rating for Amplifon, contributing to a current average rating of "Moderate Buy".
  • Despite reporting a miss on earnings with $0.25 EPS compared to an estimated $0.34, Amplifon achieved revenues of $698.20 million exceeding analyst expectations.
  • Interested in Amplifon? Here are five stocks we like better.

Amplifon S.p.A. (OTCMKTS:AMFPF - Get Free Report)'s stock price shot up 12.3% on Tuesday . The company traded as high as $18.09 and last traded at $18.09. 280 shares changed hands during trading, an increase of 612% from the average session volume of 39 shares. The stock had previously closed at $16.11.

Analysts Set New Price Targets

Separately, Morgan Stanley reaffirmed an "overweight" rating on shares of Amplifon in a research report on Wednesday, June 25th. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy".

View Our Latest Stock Analysis on AMFPF

Amplifon Stock Performance

The stock has a fifty day moving average price of $17.44 and a two-hundred day moving average price of $20.44. The company has a market cap of $4.08 billion, a P/E ratio of 29.66 and a beta of 0.34. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.61 and a quick ratio of 0.53.

Amplifon (OTCMKTS:AMFPF - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.25 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.09). Amplifon had a net margin of 5.20% and a return on equity of 13.70%. The business had revenue of $698.20 million during the quarter, compared to analyst estimates of $625.73 million.

About Amplifon

(Get Free Report)

Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amplifon Right Now?

Before you consider Amplifon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amplifon wasn't on the list.

While Amplifon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.